Literature DB >> 20640040

Spongipyran Synthetic Studies. Evolution of a Scalable Total Synthesis of (+)-Spongistatin 1.

Amos B Smith1, Chris Sfouggatakis, Christina A Risatti, Jeffrey B Sperry, Wenyu Zhu, Victoria A Doughty, Takashi Tomioka, Dimitar B Gotchev, Clay S Bennett, Satoshi Sakamoto, Onur Atasoylu, Shohei Shirakami, David Bauer, Makoto Takeuchi, Jyunichi Koyanagi, Yasuharu Sakamoto.   

Abstract

Three syntheses of the architecturally complex, cytotoxic marine macrolide (+)-spongistatin 1 (1) are reported. Highlights of the first-generation synthesis include: use of a dithiane multicomponent linchpin coupling tactic for construction of the AB and CD spiroketals, and their union via a highly selective Evans boron-mediated aldol reaction en route to an ABCD aldehyde; introduction of the C(44)-C(51) side chain via a Lewis acid-mediated ring opening of a glucal epoxide with an allylstannane to assemble the EF subunit; and final fragment union via Wittig coupling of the ABCD and EF subunits to form the C(28)-C(29) olefin, followed by regioselective Yamaguchi macrolactonization and global deprotection. The second- and third- generation syntheses, designed with the goal of accessing one gram of (+)-spongistatin 1 (1), maintain both the first-generation strategy for the ABCD aldehyde and final fragment union, while incorporating two more efficient approaches for construction of the EF Wittig salt. The latter combine the original chelation-controlled dithiane union of the E- and F-ring progenitors with application of a highly efficient cyanohydrin alkylation to append the F-ring side chain, in conjunction with two independent tactics to access the F-ring pyran. The first F-ring synthesis showcases a Petasis-Ferrier union/rearrangement protocol to access tetrahydropyrans, permitting the preparation of 750 mgs of the EF Wittig salt, which in turn was converted to 80 mg of (+)-spongistatin 1, while the second F-ring strategy, incorporates an organocatalytic aldol reaction as the key construct, permitting completion of 1.009 g of totally synthetic (+)-spongistatin 1 (1). A brief analysis of the three syntheses alongside our earlier synthesis of (+)-spongistatin 2 is also presented.

Entities:  

Year:  2009        PMID: 20640040      PMCID: PMC2902791          DOI: 10.1016/j.tet.2009.04.003

Source DB:  PubMed          Journal:  Tetrahedron        ISSN: 0040-4020            Impact factor:   2.457


  26 in total

1.  Total synthesis of (+)-zampanolide.

Authors:  A B Smith; I G Safonov; R M Corbett
Journal:  J Am Chem Soc       Date:  2001-12-12       Impact factor: 15.419

2.  The Spongistatins: Architecturally Complex Natural Products-Part Two: Synthesis of the C(29-51) Subunit, Fragment Assembly, and Final Elaboration to (+)-Spongistatin 2 Financial support was provided by the National Institutes of Health (National Cancer Institute) through Grant CA-70329, a NIH Postdoctoral Fellowship to C.S.B., a Japan Society for Promotion of Science Fellowship to N.M., and a Royal Society Fulbright Fellowship to V.A.D. We also thank the Daiichi Pharmaceutical Co., Ltd, and the Tanabe Seiyaku Co., Ltd for financial support. Finally we thank Dr George T. Furst, Dr. Patrick J. Carroll, and Dr. Rakesh Kohli of the University of Pennsylvania Spectroscopic Service Center for assistance in securing and interpreting high-field NMR spectra, X-ray crystal structures, and mass spectra, respectively.

Authors:  Amos B. Smith III; Qiyan Lin; Victoria A. Doughty; Linghang Zhuang; Mark D. McBriar; Jeffrey K. Kerns; Christopher S. Brook; Noriaki Murase; Kiyoshi Nakayama
Journal:  Angew Chem Int Ed Engl       Date:  2001-01-05       Impact factor: 15.336

3.  The Spongistatins: Architecturally Complex Natural Products-Part One: A Formal Synthesis of (+)-Spongistatin 1 by Construction of an Advanced ABCD Fragment Financial support was provided by the National Institutes of Health (National Cancer Institute) through Grant CA-70329, NIH Postdoctoral Fellowships to A.M.B. and W.H.M., a Japan Society for Promotion of Science Fellowship to N.M., and a Royal Society Fulbright Fellowship to V.A.D. We also thank the Daiichi Pharmaceutical Co., Ltd, and the Tanabe Seiyaku Co., Ltd for financial support. Finally we thank Dr. George T. Furst, Dr. Patrick J. Carroll, Dr. Rakesh Kohli, and Mr John Dykins of the University of Pennsylvania Spectroscopic Service Center for assistance in securing and interpreting high-field NMR spectra, X-ray crystal structures, and mass spectra.

Authors:  Amos B. Smith III; Victoria A. Doughty; Qiyan Lin; Linghang Zhuang; Mark D. McBriar; Armen M. Boldi; William H. Moser; Noriaki Murase; Kiyoshi Nakayama; Masao Sobukawa
Journal:  Angew Chem Int Ed Engl       Date:  2001-01-05       Impact factor: 15.336

4.  (+)-Discodermolide: Total Synthesis, Construction of Novel Analogues, and Biological Evaluation.

Authors:  Amos B Smith; B Scott Freeze
Journal:  Tetrahedron       Date:  2007-01-07       Impact factor: 2.457

5.  Total synthesis of (-)-okilactomycin.

Authors:  Amos B Smith; Kallol Basu; Todd Bosanac
Journal:  J Am Chem Soc       Date:  2007-11-13       Impact factor: 15.419

6.  The stereocontrolled total synthesis of altohyrtin A/spongistatin 1: fragment couplings, completion of the synthesis, analogue generation and biological evaluation.

Authors:  Ian Paterson; David Y-K Chen; Mark J Coster; José L Aceña; Jordi Bach; Debra J Wallace
Journal:  Org Biomol Chem       Date:  2005-05-24       Impact factor: 3.876

7.  A second-generation synthesis of the C1-C28 portion of the altohyrtins (spongistatins).

Authors:  Jed L Hubbs; Clayton H Heathcock
Journal:  J Am Chem Soc       Date:  2003-10-22       Impact factor: 15.419

8.  Multigram synthesis of the C29-C51 subunit and completion of the total synthesis of altohyrtin C (spongistatin 2).

Authors:  Clayton H Heathcock; Mark McLaughlin; Jesus Medina; Jed L Hubbs; Grier A Wallace; Robert Scott; Michele M Claffey; Christopher J Hayes; Gregory R Ott
Journal:  J Am Chem Soc       Date:  2003-10-22       Impact factor: 15.419

9.  Evolution of the Petasis-Ferrier union/rearrangement tactic: construction of architecturally complex natural products possessing the ubiquitous cis-2,6-substituted tetrahydropyran structural element.

Authors:  Amos B Smith; Richard J Fox; Thomas M Razler
Journal:  Acc Chem Res       Date:  2008-05       Impact factor: 22.384

10.  Gram-scale synthesis of (+)-spongistatin 1: development of an improved, scalable synthesis of the F-ring subunit, fragment union, and final elaboration.

Authors:  Amos B Smith; Takashi Tomioka; Christina A Risatti; Jeffrey B Sperry; Chris Sfouggatakis
Journal:  Org Lett       Date:  2008-08-28       Impact factor: 6.005

View more
  17 in total

1.  Phorboxazole Synthetic Studies: Design, Synthesis and Biological Evaluation of Phorboxazole A and Hemi-Phorboxazole A Related Analogues.

Authors:  Amos B Smith; Anne-Marie L Hogan; Zhuqing Liu; Thomas M Razler; Regina M Meis; Brandon I Morinaka; Tadeusz F Molinski
Journal:  Tetrahedron       Date:  2011-07-08       Impact factor: 2.457

2.  Diversity-oriented synthesis leads to an effective class of bifunctional linchpins uniting anion relay chemistry (ARC) with benzyne reactivity.

Authors:  Amos B Smith; Won-Suk Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-18       Impact factor: 11.205

Review 3.  Natural Products in the "Marketplace": Interfacing Synthesis and Biology.

Authors:  Benjamin J Huffman; Ryan A Shenvi
Journal:  J Am Chem Soc       Date:  2019-02-13       Impact factor: 15.419

Review 4.  Conformation-activity relationships of polyketide natural products.

Authors:  Erik M Larsen; Matthew R Wilson; Richard E Taylor
Journal:  Nat Prod Rep       Date:  2015-08       Impact factor: 13.423

5.  Exploiting pseudo C2-symmetry for an efficient synthesis of the F-ring of the spongistatins.

Authors:  Paul S Tanis; Joshua R Infantine; James L Leighton
Journal:  Org Lett       Date:  2013-10-10       Impact factor: 6.005

6.  In vitro and in vivo anticancer activity of (+)-spongistatin 1.

Authors:  Qunli Xu; Kuan-Chun Huang; Karen Tendyke; Joanne Marsh; Junke Liu; Dayong Qiu; Bruce A Littlefield; Kenichi Nomoto; Onur Atasoylu; Christina A Risatti; Jeffrey B Sperry; Amos B Smith
Journal:  Anticancer Res       Date:  2011-09       Impact factor: 2.480

7.  Design, synthesis, and biological evaluation of diminutive forms of (+)-spongistatin 1: lessons learned.

Authors:  Amos B Smith; Christina A Risatti; Onur Atasoylu; Clay S Bennett; Junke Liu; Hongsheng Cheng; Karen TenDyke; Qunli Xu
Journal:  J Am Chem Soc       Date:  2011-08-12       Impact factor: 15.419

8.  Interactions of halichondrin B and eribulin with tubulin.

Authors:  Ruoli Bai; Tam Luong Nguyen; James C Burnett; Onur Atasoylu; Murray H G Munro; George R Pettit; Amos B Smith; Rick Gussio; Ernest Hamel
Journal:  J Chem Inf Model       Date:  2011-05-13       Impact factor: 4.956

Review 9.  Natural products: a continuing source of novel drug leads.

Authors:  Gordon M Cragg; David J Newman
Journal:  Biochim Biophys Acta       Date:  2013-02-18

10.  Toward a more step-economical and scalable synthesis of spongistatin 1 to facilitate cancer drug development efforts.

Authors:  Samuel K Reznik; James L Leighton
Journal:  Chem Sci       Date:  2013-04-01       Impact factor: 9.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.